Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct;55(5):294-302.
doi: 10.1055/s-0044-1787103. Epub 2024 May 22.

Potentially Life-Threatening Interaction between Opioids and Intrathecal Baclofen in Individuals with a Childhood-Onset Neurological Disorder: A Case Series and Review of the Literature

Affiliations
Review

Potentially Life-Threatening Interaction between Opioids and Intrathecal Baclofen in Individuals with a Childhood-Onset Neurological Disorder: A Case Series and Review of the Literature

Liza M M van Dijk et al. Neuropediatrics. 2024 Oct.

Abstract

Background: Spasticity and dystonia are movement impairments that can occur in childhood-onset neurological disorders. Severely affected individuals can be treated with intrathecal baclofen (ITB). Concomitant use of ITB and opioids has been associated with central nervous system (CNS) depression. This study aims to describe the clinical management of this interaction, based on a case series and review of literature.

Methods: Four individuals with childhood-onset CNS disorders (age 8-24) and CNS-depressant overdose symptoms after the concomitant use of ITB and opioids are described. The Drug Interaction Probability Scale (DIPS) was calculated to assess the cause-relationship (doubtful <2, possible 2-4, probable 5-8, and highly probable >8) of the potential drug-drug interaction. A literature review of similar previously reported cases and the possible pharmacological mechanisms of opioid-baclofen interaction is provided.

Results: After ITB and opioid co-administration, three out of four patients had decreased consciousness, and three developed respiratory depression. DIPS scores indicated a possible cause-relationship in one patient (DIPS: 4) and a probable cause-relationship in the others (DIPS: 6, 6, and 8). Discontinuation or adjusting ITB or opioid dosages resulted in clinical recovery. All patients recovered completely. In the literature, two articles describing nine unique cases were found.

Conclusion: Although the opioid-ITB interaction is incompletely understood, concomitant use may enhance the risk of symptoms of CNS-depressant overdose, which are potentially life-threatening. If concomitant use is desirable, we strongly recommend to closely monitor these patients to detect interaction symptoms early. Awareness and monitoring of the potential opioid-ITB interaction is essential to reduce the risk of severe complications.

PubMed Disclaimer

Conflict of interest statement

None declared.

Similar articles

References

    1. Klein C, Münchau A. Progressive dystonia. Handb Clin Neurol. 2013;113:1889–1897. - PubMed
    1. Brett E, Lake B. Progressive neurometabolic brain diseases. Pediatric Neurology. 1997;3:143–200.
    1. Dyken P, Krawiecki N. Neurodegenerative diseases of infancy and childhood. Ann Neurol. 1983;13(04):351–364. - PubMed
    1. Rosenbaum P, Paneth N, Leviton A et al.A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109:8–14. - PubMed
    1. Buizer A I, Martens B HM, Grandbois van Ravenhorst C, Schoonmade L J, Becher J G, Vermeulen R J. Effect of continuous intrathecal baclofen therapy in children: a systematic review. Dev Med Child Neurol. 2019;61(02):128–134. - PMC - PubMed